JBIO
Jade Biosciences·NASDAQ
--
--(--)
--
--(--)
5.46 / 10
Netural
Analyst coverage is limited but decisively positive—only one active analyst (Strong Buy) with a 100% historical win rate. Fund flows are encouraging: Small, Medium, and Large inflow ratios exceed 0.50, signaling buying interest at multiple scales, though block and extra-large flows are negative. The synergy of bullish analyst sentiment and constructive fund movement supports the technical optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-07
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for JBIO?
- JBIO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.46/10 (Netural).
